Cytokinetics, Incorporated (BIT:1CYTK)
Italy · Delayed Price · Currency is EUR 51.00
0.00 (0.00%)
At close: Oct 7, 2025
Cytokinetics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Cash & Equivalents | 74.94 | 94.86 | 113.02 | 65.58 | 112.67 | 82.99 | Upgrade |
Short-Term Investments | 783.2 | 981.16 | 501.8 | 717 | 358.97 | 381.08 | Upgrade |
Cash & Short-Term Investments | 858.14 | 1,076 | 614.82 | 782.58 | 471.64 | 464.06 | Upgrade |
Cash Growth | -18.80% | 75.01% | -21.44% | 65.93% | 1.63% | 106.15% | Upgrade |
Accounts Receivable | 8.41 | 16.65 | 1.28 | 0.15 | 51.82 | 4.42 | Upgrade |
Other Current Assets | 20 | 15.28 | 11.94 | 12.46 | 12.22 | 5.74 | Upgrade |
Total Current Assets | 886.54 | 1,108 | 628.05 | 795.19 | 535.67 | 474.22 | Upgrade |
Net Property, Plant & Equipment | 76.12 | 75.16 | 78.99 | 82.74 | 73.14 | 2.92 | Upgrade |
Long-Term Investments | 178.2 | 145.06 | 40.53 | 46.71 | 152.05 | 36.95 | Upgrade |
Other Long-Term Assets | 14.55 | 7.71 | 8 | 9.69 | 7.19 | 6.36 | Upgrade |
Total Assets | 1,226 | 1,402 | 824.32 | 1,015 | 841.32 | 533.8 | Upgrade |
Accounts Payable | 16.23 | 20.37 | 21.51 | 25.61 | 21.09 | 8.05 | Upgrade |
Accrued Expenses | 52.32 | 55.32 | 42.64 | 44.1 | 34.37 | 19.32 | Upgrade |
Current Portion of Long-Term Debt | 14.4 | 11.52 | 10.08 | 0.96 | - | - | Upgrade |
Current Portion of Leases | 19.59 | 18.98 | 17.89 | 12.83 | 14.86 | 2.79 | Upgrade |
Unearned Revenue | 1.34 | 52.37 | - | - | - | - | Upgrade |
Other Current Liabilities | 27.19 | 21.11 | 10.56 | 1.12 | 1.54 | 1.05 | Upgrade |
Total Current Liabilities | 131.06 | 179.67 | 102.68 | 84.62 | 71.86 | 31.2 | Upgrade |
Long-Term Debt | 713.05 | 645.6 | 607.37 | 609.62 | 142.84 | 135.71 | Upgrade |
Long-Term Leases | 111.03 | 112.58 | 120.43 | 126.9 | 112.23 | 0.44 | Upgrade |
Other Long-Term Liabilities | 639.22 | 599.19 | 380.16 | 301.55 | 270.53 | 253.07 | Upgrade |
Total Long-Term Liabilities | 1,463 | 1,357 | 1,108 | 1,038 | 525.6 | 389.22 | Upgrade |
Total Liabilities | 1,594 | 1,537 | 1,211 | 1,123 | 597.46 | 420.42 | Upgrade |
Common Stock | 0.12 | 0.12 | 0.1 | 0.09 | 0.08 | 0.07 | Upgrade |
Additional Paid-in Capital | 2,629 | 2,564 | 1,726 | 1,482 | 1,452 | 1,105 | Upgrade |
Accumulated Other Comprehensive Income | -0.16 | 2.4 | -0.01 | -3.59 | -0.87 | 0.15 | Upgrade |
Retained Earnings | -2,998 | -2,702 | -2,112 | -1,586 | -1,208 | -992.31 | Upgrade |
Shareholders' Equity | -368.72 | -135.37 | -386.32 | -107.9 | 243.86 | 113.38 | Upgrade |
Total Liabilities & Equity | 1,226 | 1,402 | 824.32 | 1,015 | 841.32 | 533.8 | Upgrade |
Total Debt | 858.06 | 788.68 | 755.77 | 750.3 | 269.93 | 138.94 | Upgrade |
Net Cash (Debt) | 0.08 | 287.34 | -140.95 | 32.28 | 201.71 | 325.12 | Upgrade |
Net Cash Growth | -99.97% | - | - | -84.00% | -37.96% | 265.13% | Upgrade |
Net Cash Per Share | 0.00 | 2.57 | -1.46 | 0.36 | 2.62 | 5.04 | Upgrade |
Book Value | -368.72 | -135.37 | -386.32 | -107.9 | 243.86 | 113.38 | Upgrade |
Book Value Per Share | -3.11 | -1.21 | -4.00 | -1.20 | 3.17 | 1.76 | Upgrade |
Tangible Book Value | -368.72 | -135.37 | -386.32 | -107.9 | 243.86 | 113.38 | Upgrade |
Tangible Book Value Per Share | -3.11 | -1.21 | -4.00 | -1.20 | 3.17 | 1.76 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.